Jinyu Bio-technology Co., Ltd. (600201.SS)

CNY 7.14

(0.85%)

Market Cap (In CNY)

7.84 Billion

Revenue (In CNY)

1.59 Billion

Net Income (In CNY)

283.63 Million

Avg. Volume

11.6 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.62-10.95
PE
-
EPS
-
Beta Value
0.572
ISIN
CNE000000Y37
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Jing Zhang
Employee Count
-
Website
https://www.jinyu.com.cn
Ipo Date
1999-01-15
Details
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sales of veterinary biological products in China. It offers vaccines for foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever for pigs, poultry, ruminants, and pets. The company was formerly known as Inner Mongolia Jinyu Group Co., Ltd. and changed its name to Jinyu Bio-technology Co., Ltd. in December 2015. Jinyu Bio-technology Co., Ltd. was founded in 1992 and is based in Hohhot, China.

More Stocks